Johri M, Kaplan E H, Levi J, Novick A
Department of Health Administration, University of Montreal.
AIDS Public Policy J. 1999 Winter;14(4):136-46.
A system of HIV surveillance based on AIDS case reporting is no longer adequate to monitor the epidemic of HIV/AIDS in the U.S. We are now faced with the challenge of designing an effective system of HIV surveillance. The "New Approaches to HIV Surveillance: Means and Ends" conference emphasized that there are several alternatives, each with strengths and limitations. The CDC has recommended that all states adopt a system of HIV surveillance based on case reporting. Although it has not specified that such systems need be name-based, CDC appears to reward states that adopt name-reporting systems. The rationale for this stance should be reviewed and made explicit. Name reporting may be superior in some respects to a system of case reports based on unique identifiers (UIs), especially in its greater ability to link surveillance activities to follow up at the individual level. Neither a name-reporting nor a UI approach to case reporting would provide HIV incidence data. The only currently envisioned means of providing incidence data is statistical estimation based on "snapshot estimates" of HIV incidence in sample cohorts. Calibration of this new instrument for HIV incidence estimation against existing data or through field trials is of critical importance.
基于艾滋病病例报告的艾滋病毒监测系统已不足以监测美国的艾滋病毒/艾滋病疫情。我们现在面临着设计一个有效的艾滋病毒监测系统的挑战。“艾滋病毒监测的新方法:手段与目的”会议强调,有几种备选方案,每种方案都有优点和局限性。疾病控制与预防中心(CDC)建议所有州采用基于病例报告的艾滋病毒监测系统。尽管CDC没有明确规定此类系统必须以姓名为基础,但它似乎对采用姓名报告系统的州给予奖励。应审查并明确这一立场的基本原理。在某些方面,姓名报告可能优于基于唯一标识符(UI)的病例报告系统,特别是在将监测活动与个体层面的随访相联系方面具有更强的能力。姓名报告法和UI病例报告法都无法提供艾滋病毒发病率数据。目前唯一设想的提供发病率数据的方法是基于样本队列中艾滋病毒发病率的“快照估计”进行统计估计。将这种新的艾滋病毒发病率估计工具与现有数据进行校准或通过现场试验进行校准至关重要。